Article
Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNalpha2a shows earlier viral decline than peg-IFNalpha2b in combination therapy with ribavirin.
Medical science monitor : international medical journal of experimental and clinical research - 1 Dec 2011
Fujino Tatsuya, Nakamuta Makoto, Aoyagi Yoko, Kohjima Motoyuki, Satoh Takeaki, Fukuda Mika, Ishibashi Hiromi, Yatsuhashi Hiroshi, Enjoji Munechika
Abstract excerpt
BACKGROUND: We aimed to assess differences in early viral dynamics following treatment with either peg-IFNalpha2a or peg-IFNalpha2b in combination with ribavirin in patients with chronic genotype 1b HCV infection. MATERIAL/METHODS: Sixty-one patients in the peg-IFNalpha2a + ribavirin treatment (group alpha2a) and 88 patients in the peg-IFNalpha2b + ribavirin treatment (group alpha2b) were retrospectively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.